Drug intelligence / Profile preview

xianlinggubao + eucommia ulmoides

Development stage
Unknown
Lead developer
Sinopharm Group Tongjitang Pharmaceutical
Administration
Oral
01

Overview

Xianlinggubao + eucommia ulmoides is a combination of the traditional Chinese medicine formulation Xianlinggubao (仙灵骨葆) and Eucommia ulmoides (杜仲). Xianlinggubao is a multi-herb formula containing Epimedium (淫羊藿), Dipsacus asper (续断), Salvia miltiorrhiza (丹参), Anemarrhena asphodeloides (知母), Psoralea corylifolia (补骨脂), and Rehmannia glutinosa (地黄). It is used to tonify the liver and kidney, strengthen bones and tendons, promote blood circulation, relieve pain, and treat osteoporosis, bone fractures, osteoarthritis, avascular necrosis of bone, and related conditions. Eucommia ulmoides is a medicinal plant traditionally used for its bone-strengthening properties; it has demonstrated estrogen-like effects in animal studies by increasing serum estradiol levels and improving bone density. The combination aims to synergistically enhance bone formation, inhibit bone resorption, modulate hormone levels such as estrogen/testosterone/osteocalcin/calcitonin/parathyroid hormone/interleukin-6/tumor necrosis factor-alpha/insulin-like growth factor-1/bone morphogenetic protein-2/receptor activator of nuclear factor kappa-B ligand/osteoprotegerin pathways involved in osteoporosis pathogenesis. The mechanism involves promoting osteoblast activity/maturation/mineralization while inhibiting osteoclast-mediated resorption.

Other names
仙灵骨葆 + 杜仲
02

Targets

ESR1 (ERα)

Beyond the preview

Go deeper on xianlinggubao + eucommia ulmoides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xianlinggubao + eucommia ulmoides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call